Multi-center MRD Registry for Inflammatory Breast Cancer

Summary

To collect data from participants with IBC who may have had MRD testing and may have surgery in the future.

Eligibility

Inclusion Criteria:

* Female or males ≥18 years of age with the ability to understand and sign a written
* Participants who have a clinical diagnosis of stage III or IV inflammatory breast cancer (IBC).
* Participants who are planning to have or already completed a minimum of one blood draw for Signatera testing, for which the result and clinical data can be deposited into the study database.
* Participants must be within eight months of diagnosis and have not undergone breast surgery for this diagnosis of breast cancer.
* Participants must be English-speaking.

Exclusion Criteria:

\-

Conditions2

Locations1 site

Browse More Trials